77 related articles for article (PubMed ID: 20649849)
1. Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis.
Marte A; Cavallero A; Morando S; Uccelli A; Raiteri M; Fedele E
J Neurochem; 2010 Oct; 115(2):343-52. PubMed ID: 20649849
[TBL] [Abstract][Full Text] [Related]
2. CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
Di Prisco S; Merega E; Milanese M; Summa M; Casazza S; Raffaghello L; Pistoia V; Uccelli A; Pittaluga A
Neuropharmacology; 2013 Dec; 75():337-46. PubMed ID: 23958452
[TBL] [Abstract][Full Text] [Related]
3. RANTES-mediated control of excitatory amino acid release in mouse spinal cord.
Di Prisco S; Summa M; Chellakudam V; Rossi PI; Pittaluga A
J Neurochem; 2012 May; 121(3):428-37. PubMed ID: 22385043
[TBL] [Abstract][Full Text] [Related]
4. Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of the wobbler mouse: a model of motor neuron disease.
Bonanno G; Fumagalli E; Milanese M; Zappettini S; Mennini T
Neurochem Int; 2009 Sep; 55(5):302-6. PubMed ID: 19576518
[TBL] [Abstract][Full Text] [Related]
5. Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.
Raiteri L; Stigliani S; Patti L; Usai C; Bucci G; Diaspro A; Raiteri M; Bonanno G
J Neurosci Res; 2005 May; 80(3):424-33. PubMed ID: 15789377
[TBL] [Abstract][Full Text] [Related]
6. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent.
Recks MS; Addicks K; Kuerten S
Neurosci Lett; 2011 May; 494(3):227-31. PubMed ID: 21406210
[TBL] [Abstract][Full Text] [Related]
8. Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis.
Olivero G; Taddeucci A; Vallarino G; Trebesova H; Roggeri A; Gagliani MC; Cortese K; Grilli M; Pittaluga A
Br J Pharmacol; 2024 Jun; 181(12):1812-1828. PubMed ID: 38369641
[TBL] [Abstract][Full Text] [Related]
9. An electrophysiological model of spinal transmission deficits in mouse experimental autoimmune encephalomyelitis.
Hanak SE; Reilly EM; Wotanis J; Zhu B; Pulicicchio C; McMonagle-Strucko K; Wettstein JG; Black MD
J Pharmacol Exp Ther; 2004 Jan; 308(1):214-20. PubMed ID: 14566007
[TBL] [Abstract][Full Text] [Related]
10. Functional adaptation of presynaptic chemokine receptors in EAE mouse central nervous system.
Di Prisco S; Merega E; Pittaluga A
Synapse; 2014 Nov; 68(11):529-35. PubMed ID: 25092801
[TBL] [Abstract][Full Text] [Related]
11. Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis.
Bonfiglio T; Olivero G; Vergassola M; Di Cesare Mannelli L; Pacini A; Iannuzzi F; Summa M; Bertorelli R; Feligioni M; Ghelardini C; Pittaluga A
Neuropharmacology; 2019 Feb; 145(Pt A):75-86. PubMed ID: 29402503
[TBL] [Abstract][Full Text] [Related]
12. In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis.
Milanese M; Zappettini S; Jacchetti E; Bonifacino T; Cervetto C; Usai C; Bonanno G
J Neurochem; 2010 Apr; 113(2):489-501. PubMed ID: 20132478
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
[TBL] [Abstract][Full Text] [Related]
14. Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice.
Jansson L; Olsson T; Höjeberg B; Holmdahl R
Eur J Immunol; 1991 Mar; 21(3):693-9. PubMed ID: 1707002
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein.
Pedrazzi M; Raiteri L; Bonanno G; Patrone M; Ledda S; Passalacqua M; Milanese M; Melloni E; Raiteri M; Pontremoli S; Sparatore B
J Neurochem; 2006 Nov; 99(3):827-38. PubMed ID: 16911580
[TBL] [Abstract][Full Text] [Related]
16. Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels.
Raiteri L; Stigliani S; Siri A; Passalacqua M; Melloni E; Raiteri M; Bonanno G
Biochem Pharmacol; 2005 Jan; 69(1):159-68. PubMed ID: 15588724
[TBL] [Abstract][Full Text] [Related]
17. GABA transporter type 1 (GAT-1) uptake inhibition reduces stimulated aspartate and glutamate release in the dorsal spinal cord in vivo via different GABAergic mechanisms.
Smith CG; Bowery NG; Whitehead KJ
Neuropharmacology; 2007 Dec; 53(8):975-81. PubMed ID: 17981306
[TBL] [Abstract][Full Text] [Related]
18. Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
Zagon IS; Rahn KA; Bonneau RH; Turel AP; McLaughlin PJ
Brain Res; 2010 Jan; 1310():154-61. PubMed ID: 19931226
[TBL] [Abstract][Full Text] [Related]
19. The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain.
Andó RD; Sperlágh B
Brain Res Bull; 2013 Apr; 93():80-5. PubMed ID: 23047057
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
